A retrospective study evaluating factors associated with poor response to Aflibercept therapy in neovascular age-related macular degeneration patients previously treated with Ranibizumab or Bevacizumab
Latest Information Update: 12 Jul 2017
At a glance
- Drugs Aflibercept (Primary)
- Indications Wet age-related macular degeneration
- Focus Therapeutic Use
- 12 Jul 2017 New trial record